Innovative Biosensors, Cambrex Establish Manufacturing Relationship
Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens, and Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporation (NYSE: CBM), today announced that they have signed an agreement for Cambrex to supply cGMP manufacturing services.
Innovative Biosensors, Inc. develops, manufactures, and markets pathogen tests for infectious diseases within the food safety and human clinical markets. Under the agreement, Cambrex Bio Science will provide cGMP (current Good Manufacturing Processes) production services for the manufacture of IBI’s human clinical testing reagents. Production will take place in Cambrex’s Walkersville, Maryland, facility.
October 4, 2005